Private equity firm Advent International has signed a definitive agreement to invest $175 million (about ₹1,500 crore) for a significant minority stake in Felix Pharmaceuticals Pvt. Ltd, an Ireland-headquartered company focused on developing and manu…
Advent to acquire significant minority stake in animal drug maker Felix Pharmaceuticals for $175 million
